SENORES — Senores Pharmaceuticals Balance Sheet
0.000.00%
- IN₹32.92bn
- IN₹36.07bn
- IN₹3.98bn
- 11
- 13
- 99
- 34
Annual balance sheet for Senores Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 32.1 | 1 | 131 | 3,855 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 207 | 402 | 1,927 | 2,701 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 271 | 513 | 2,509 | 7,224 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 61.2 | 153 | 1,791 | 2,524 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 592 | 1,311 | 6,219 | 12,269 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 98.8 | 519 | 2,475 | 2,407 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 226 | 856 | 4,176 | 4,407 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 366 | 455 | 2,043 | 7,862 |
| Total Liabilities & Shareholders' Equity | 592 | 1,311 | 6,219 | 12,269 |
| Total Common Shares Outstanding |